From: Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer
Cluster A
Cluster B
Cluster C
Subpopulation
Mean
CD3 pre-CT
51.7
352.0
255.1
CD4 pre-CT
15.7
142.6
110.6
CD8 pre-CT
0.0
129.9
CD20 pre-CT
4.5
122.0
43.9
FOXP3 pre-CT
3.1
19.3
2.3
CD68 pre-CT
17.5
67.5
34.3